Your browser doesn't support javascript.
loading
Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.
Islam, Shariful; Espitia, Claudia M; Persky, Daniel O; Carew, Jennifer S; Nawrocki, Steffan T.
Affiliation
  • Islam S; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Espitia CM; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Persky DO; Division of Hematology and Oncology, Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Carew JS; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
  • Nawrocki ST; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Cancer Center, Tucson, AZ 85724, USA.
Viruses ; 13(7)2021 07 20.
Article in En | MEDLINE | ID: mdl-34372612
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reoviridae / Leukemia-Lymphoma, Adult T-Cell / Oncolytic Viruses / STAT5 Transcription Factor / Janus Kinases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Viruses Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reoviridae / Leukemia-Lymphoma, Adult T-Cell / Oncolytic Viruses / STAT5 Transcription Factor / Janus Kinases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Viruses Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza